AMP-activated protein kinase: the current landscape for drug development
GR Steinberg, D Carling - Nature reviews Drug discovery, 2019 - nature.com
Since the discovery of AMP-activated protein kinase (AMPK) as a central regulator of energy
homeostasis, many exciting insights into its structure, regulation and physiological roles …
homeostasis, many exciting insights into its structure, regulation and physiological roles …
[HTML][HTML] Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
S Chen, D Gan, S Lin, Y Zhong, M Chen, X Zou… - Theranostics, 2022 - ncbi.nlm.nih.gov
Aging is a natural process, which plays a critical role in the pathogenesis of a variety of
diseases, ie, aging-related diseases, such as diabetes, osteoarthritis, Alzheimer disease …
diseases, ie, aging-related diseases, such as diabetes, osteoarthritis, Alzheimer disease …
Metformin and systemic metabolism
L He - Trends in Pharmacological Sciences, 2020 - cell.com
Metformin can improve patients' hyperglycemia through significant suppression of hepatic
glucose production. However, up to 300 times higher concentrations of metformin …
glucose production. However, up to 300 times higher concentrations of metformin …
Metformin: a review of its potential indications
YW Wang, SJ He, X Feng, J Cheng… - Drug design …, 2017 - Taylor & Francis
Metformin is the most commonly prescribed drug for type 2 diabetes mellitus. In recent years,
in addition to glucose lowering, several studies have presented evidence suggesting some …
in addition to glucose lowering, several studies have presented evidence suggesting some …
Metformin in patients with and without diabetes: a paradigm shift in cardiovascular disease management
With an increasing global burden of coronary artery disease (CAD), early detection and
timely management of risk factors are crucial to reduce morbidity and mortality in such …
timely management of risk factors are crucial to reduce morbidity and mortality in such …
Pathogenesis of lipid disorders in insulin resistance: a brief review
P Bjornstad, RH Eckel - Current diabetes reports, 2018 - Springer
Purpose of review Insulin resistance (IR) is recognized to play an important role in the
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …
pathogenesis of dyslipidemia. This review summarizes the complex interplay between IR …
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
MF Van Stee, AA de Graaf, AK Groen - Cardiovascular diabetology, 2018 - Springer
Patients with diabetes type 2 have an increased risk for cardiovascular disease and
commonly use combination therapy consisting of the anti-diabetic drug metformin and a …
commonly use combination therapy consisting of the anti-diabetic drug metformin and a …
Metformin role in Parkinson's disease: a double-sword effect
Parkinson's disease (PD) is a common neurodegenerative disease developed due to the
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …
degeneration of dopaminergic neurons in the substantia nigra. There is no single effective …
Metformin: Therapeutic profile in the treatment of type 2 diabetes
CJ Bailey - Diabetes, Obesity and Metabolism, 2024 - Wiley Online Library
Metformin (dimethyl‐biguanide) can claim its origins in the use of Galega officinalis as a
plant treatment for symptoms ascribed to diabetes. Since the first clinical use of metformin as …
plant treatment for symptoms ascribed to diabetes. Since the first clinical use of metformin as …
Molecular mechanisms of metformin for diabetes and cancer treatment
M Li, X Li, H Zhang, Y Lu - Frontiers in physiology, 2018 - frontiersin.org
Metformin has been the first-line drug treatment for hyperglycemia and insulin resistance for
over 50 years. However, the molecular basis of its therapeutic role remained incompletely …
over 50 years. However, the molecular basis of its therapeutic role remained incompletely …